Melatonin serves as a novel treatment in cystic fibrosis and inhibits cystic fibrosis through TGF-β1/Smad and EMT
Y. Zhang, S. Gong, W. He, J. Yuan, D. Dong, J. Zhang, H. Wang, B. Chen
This study shows melatonin reduces bladder fibrosis by inhibiting the TGF-β1/Smad pathway and epithelial-mesenchymal transition (EMT) in both in vitro and in vivo models.
bioRxiv · Nov 15, 2023 · PreprintPharmacology & Toxicology